We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CyGenics’ Subsidiary Signs Distribution Agreement with CombiMatrix
News

CyGenics’ Subsidiary Signs Distribution Agreement with CombiMatrix

CyGenics’ Subsidiary Signs Distribution Agreement with CombiMatrix
News

CyGenics’ Subsidiary Signs Distribution Agreement with CombiMatrix

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "CyGenics’ Subsidiary Signs Distribution Agreement with CombiMatrix"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

CyGenics Limited has announced that its wholly-owned subsidiary, Cell Sciences Ltd, has entered into a nonexclusive distribution agreement with CombiMatrix group of Acacia Research Corporation to distribute CombiMatrix products and services in Singapore.

Under the terms of the agreement, Cell Sciences will market and sell CustomArrays™, CatalogArrays™ and CustomArray Synthesizers, which are semiconductor-based tools for use in identifying and determining the roles of genes, and the recently introduced Influenza Research Microarray, to the Southeast Asian market.

"We are very pleased to have expanded our distribution network into Southeast Asia," said Michael Tognotti, Vice President of Sales and Marketing for CombiMatrix.

"I am confident that by joining forces with Cell Sciences, we can accelerate sales growth and enhance our collective market share."

"Cell Sciences has identified CombiMatrix’s platform technology to rapidly produce customizable arrays for applications in the areas of proteomics, genomics and nanotechnology," said Mr Steven Fang, Group CEO, CyGenics.

"This has a huge market potential in the Asia Pacific region and we look forward to a long and fruitful relationship."

Advertisement